The rearrangement of anaplastic lymphoma kinase (ALK), c-ros oncogene 1, receptor tyrosine kinase (ROS1), and ret proto-oncogene (RET) play a role on driving the occurrence and development of NSCLC (Takeuchi et al., 2012; Cancer Genome Atlas Research, 2014). This evidence concerns the gene RET and non-small cell lung carcinoma.